Researchers have discovered why the lungs are often targeted by metastasizing cancer cells, pinpointing the amino acid ...

SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Non-Small Cell Lung Cancer.

Pembrolizumab biosimilar is under clinical development by Formycon and currently in Phase III for Non-Small Cell Lung Cancer.

Ian Smith is reflecting on 'good news' in his battle against terminal lung cancer.The Neighbours legend, who announced his ...

The early detection of cancer in patients in Sussex has risen to its highest ever level, according to new NHS analysis. Of ...

It is depressing and frustrating to see how nicotine addiction continues through the generations. Smoking continues to be the ...